Impact of Abutment Screw Torque on Marginal Bone Loss

NCT ID: NCT07234552

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this clinical trial is to evaluate the impact of different torque values applied during transmucosal abutment placement in dental implants on marginal bone loss and peri-implant parameters, including the patient's perception of the treatment.

The main questions the study aims to answer are:

1. Is there any difference in marginal bone loss between abutments torqued at 15 Ncm, 30 Ncm, and submerged implants without immediate transmucosal connection?
2. Are there differences in microleakage between the different torque levels?
3. How do these torque values affect peri-implant soft tissues and patient satisfaction?
4. Does the applied torque influence the patient's quality of life after the prosthetic phase?

Each participant will receive three dental implants during the same surgical procedure. One of the following approaches will be applied to each implant:

1. A transmucosal abutment torqued to 15 Ncm
2. A transmucosal abutment torqued to 30 Ncm
3. A healing cap without transmucosal connection (submerged implant)

After implant placement, clinical and radiographic assessments will be performed to measure marginal bone loss and peri-implant parameters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to analyze how different torque levels applied during transmucosal abutment placement on dental implants influence peri-implant tissue health and other relevant clinical parameters. A randomized clinical trial will be conducted in which each participant will receive three dental implants. Each implant will be assigned to one of the following conditions: an abutment torqued to 15 Ncm, an abutment torqued to 30 Ncm, and a submerged implant with a healing cap, without immediate transmucosal connection.

This intra-individual design enables direct comparison of outcomes while minimizing inter-individual variability that could affect the results.

Throughout the treatment process, various data will be collected. During surgery, patient-reported comfort levels will be recorded. Following prosthesis placement, standard clinical measurements will be performed, including peri-implant probing, bleeding on probing, inflammation, and radiographic evaluation of marginal bone loss.

Additionally, patient-reported outcomes during the first week after the initiation of the prosthetic phase will be documented, including pain levels, inflammation, and analgesic use. Overall satisfaction and the impact of treatment on quality of life will also be assessed using a Likert-type scale, focusing on functions such as chewing, speech, sleep, and daily activities.

The goal of this study is to determine whether the torque applied during abutment connection has a clinically relevant effect on both peri-implant tissue response and patient perception of the treatment. The findings may contribute to improved clinical guidelines in implant dentistry and enhance long-term treatment outcomes.

The study protocol has been approved by the relevant ethics committee and will comply with all applicable clinical research regulations. All participants will provide written informed consent prior to enrollment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Soft Tissues According to the Abutment Torque Microleakage Accordint to the Abutment Torque PROMS According to the Abutment Torque Marginal Bone Loss According to the Abutment Torque

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transmucosal Abutment - 15 Ncm

Group Type EXPERIMENTAL

Abutment torqued to 15 Ncm

Intervention Type PROCEDURE

A dental implant surgery will be performed in which three implants will be placed. On one of them, a 2 mm slim abutment will be connected with a torque of 15 Ncm; on another, the same abutment will be connected with a torque of 30 Ncm; and on the third, a 2 mm healing cap will be placed and the implant will be left submerged for a subsequent second-stage surgery.

Transmucosal Abutment - 30 Ncm

Group Type EXPERIMENTAL

Pilar torqued to 30 Ncm

Intervention Type PROCEDURE

A dental implant surgery will be performed in which three implants will be placed. On one of them, a 2 mm slim abutment will be connected with a torque of 15 Ncm; on another, the same abutment will be connected with a torque of 30 Ncm; and on the third, a 2 mm healing cap will be placed and the implant will be left submerged for a subsequent second-stage surgery.

Submerged Healing Cap (No Transmucosal Connection)

Group Type EXPERIMENTAL

2 mm healing cap

Intervention Type PROCEDURE

A dental implant surgery will be performed in which three implants will be placed. On one of them, a 2 mm slim abutment will be connected with a torque of 15 Ncm; on another, the same abutment will be connected with a torque of 30 Ncm; and on the third, a 2 mm healing cap will be placed and the implant will be left submerged for a subsequent second-stage surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abutment torqued to 15 Ncm

A dental implant surgery will be performed in which three implants will be placed. On one of them, a 2 mm slim abutment will be connected with a torque of 15 Ncm; on another, the same abutment will be connected with a torque of 30 Ncm; and on the third, a 2 mm healing cap will be placed and the implant will be left submerged for a subsequent second-stage surgery.

Intervention Type PROCEDURE

Pilar torqued to 30 Ncm

A dental implant surgery will be performed in which three implants will be placed. On one of them, a 2 mm slim abutment will be connected with a torque of 15 Ncm; on another, the same abutment will be connected with a torque of 30 Ncm; and on the third, a 2 mm healing cap will be placed and the implant will be left submerged for a subsequent second-stage surgery.

Intervention Type PROCEDURE

2 mm healing cap

A dental implant surgery will be performed in which three implants will be placed. On one of them, a 2 mm slim abutment will be connected with a torque of 15 Ncm; on another, the same abutment will be connected with a torque of 30 Ncm; and on the third, a 2 mm healing cap will be placed and the implant will be left submerged for a subsequent second-stage surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Posterior edentulism
* Completion of craniofacial growth
* Full-mouth plaque index and bleeding index \< 25%
* Sufficient bone height and width for implant placement without the need for bone regeneration procedures
* Presence of at least 2 mm of keratinized mucosa around the dental implant
* Stable occlusion and healthy periodontium
* Absence of medical conditions that contraindicate implant surgery, such as heavy smoking (\<10 cigarettes per day), severe bruxism, pregnancy or breastfeeding, bisphosphonate therapy, and patients undergoing chemotherapy or radiotherapy in the head and/or neck area
* Uncooperative patients

Exclusion Criteria

* Loss to follow-up
* Incorrectly parallelized periapical radiographs
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Valencia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Juan Carlos Bernabeu Mira

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paula Claver Baldovi

Role: PRINCIPAL_INVESTIGATOR

University of Valencia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Juan Carlos Bernabeu Mira

Role: CONTACT

+34 697 348 312

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UV-INV_ETICA-3792382

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.